SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-284924
Filing Date
2015-08-10
Accepted
2015-08-10 16:26:28
Documents
15
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d942622d10q.htm 10-Q 701575
2 EX-10.7 d942622dex107.htm EX-10.7 5840
3 EX-10.9 d942622dex109.htm EX-10.9 5854
4 EX-10.10 d942622dex1010.htm EX-10.10 119361
5 EX-10.12 d942622dex1012.htm EX-10.12 5880
6 EX-31.1 d942622dex311.htm EX-31.1 6260
7 EX-31.2 d942622dex312.htm EX-31.2 6260
8 EX-32.1 d942622dex321.htm EX-32.1 3977
9 EX-32.2 d942622dex322.htm EX-32.2 3992
  Complete submission text file 0001193125-15-284924.txt   4097837

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT mcrb-20150630.xml EX-101.INS 569516
11 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20150630.xsd EX-101.SCH 46665
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20150630_cal.xml EX-101.CAL 53675
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20150630_def.xml EX-101.DEF 203832
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20150630_lab.xml EX-101.LAB 408402
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20150630_pre.xml EX-101.PRE 317980
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 151041075
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences